First Time Loading...

Centogene NV
NASDAQ:CNTG

Watchlist Manager
Centogene NV Logo
Centogene NV
NASDAQ:CNTG
Watchlist
Price: 0.3999 USD 2.54%
Updated: May 14, 2024

Centogene NV
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Centogene NV
Cost of Revenue Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Centogene NV
NASDAQ:CNTG
Cost of Revenue
-€27.6m
CAGR 3-Years
-2%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Cost of Revenue
-€599.8m
CAGR 3-Years
-117%
CAGR 5-Years
-112%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Cost of Revenue
-€32.8m
CAGR 3-Years
-44%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cost of Revenue
-€404.3m
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
-3%
Formycon AG
XETRA:FYB
Cost of Revenue
-€54.8m
CAGR 3-Years
-27%
CAGR 5-Years
-18%
CAGR 10-Years
N/A

See Also

What is Centogene NV's Cost of Revenue?
Cost of Revenue
-27.6m EUR

Based on the financial report for Dec 31, 2022, Centogene NV's Cost of Revenue amounts to -27.6m EUR.

What is Centogene NV's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-13%

Over the last year, the Cost of Revenue growth was 0%. The average annual Cost of Revenue growth rates for Centogene NV have been -2% over the past three years , -13% over the past five years .